Nicotine Immunization
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Overview
Dr. Larry Kaskel is joined by Dr. Frank Vocci, Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse at the NIH. He will discuss NicVAX, an anti-smoking vaccine that keeps nicotine molecules from ever entering or affecting the brain. Tune in to find out how it works. And, more importantly, will it work?
Recommended
Details
Presenters
Overview
Dr. Larry Kaskel is joined by Dr. Frank Vocci, Director of the Division of Pharmacotherapies and Medical Consequences of Drug Abuse at the National Institute on Drug Abuse at the NIH. He will discuss NicVAX, an anti-smoking vaccine that keeps nicotine molecules from ever entering or affecting the brain. Tune in to find out how it works. And, more importantly, will it work?
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?